December 16, 2017 1:29 AM ET


Company Overview of Zambon S.p.A.

Company Overview

Zambon S.p.A. is an international pharmaceutical company that develops and manufactures drugs in various therapeutic areas, including respiratory, pain management, woman health care, central nervous system, and rare diseases. Zambon S.p.A. was formerly known as Gaetano Zambon e C. The company was founded in 1906 and is based in Bresso, Italy with production plants in Vicenza, Italy; Cadempino, Switzerland; and Haikou, China. It has operations in Belgium, France, Germany, Italy, the Netherlands, Portugal, the Russian Federation, Spain, Switzerland, the United Kingdom, China, India, Indonesia, Brazil, and Columbia. Zambon S.p.A. operates as a subsidiary of Zambon Company S.p.A.

Via Lillo del Duca, 10

Bresso, MI 20091


Founded in 1906

Key Executives for Zambon S.p.A.

Chief Executive Officer
Age: 55
Age: 53
Chief Communications Officer
Compensation as of Fiscal Year 2017.

Zambon S.p.A. Key Developments

Newron Pharmaceuticals S.p.A. and its partners Zambon S.p.A. and US WorldMeds, LLC Announces Food and Drug Administration Approval for the Use of Xadago®

Newron Pharmaceuticals S.p.A. and its partners Zambon S.p.A. and US WorldMeds, LLC announced that the Food and Drug Administration (FDA) has approved the use of Xadago® (safinamide) for the treatment of Parkinson’s disease as add-on therapy to levodopa/carbidopa. Parkinson’s disease affects an estimated 7 to 10 million patients worldwide, of whom 1 million are in the U.S.A. Marketing authorization in the EU for Xadago® was granted by the EU Commission in February 2015, and by Swissmedic in November 2015. Following the 2015 European approval and the launch in Germany, Xadago® has been launched by Zambon in 10 further European markets in 2016 including Italy, Spain, UK, Belgium, Denmark, Sweden, Luxembourg, the Netherlands, Norway, and Switzerland.

Zambon SpA Appoints Roberto Tascione as New CEO

Zambon SpA has appointed Roberto Tascione as new CEO to drive the business on a global scale. Tascione, 54 years, has a long experience in the pharmaceutical sector and started his career at Bristol Myers Squibb Italy, before leading the Primary Care and OTC divisions of Schering Plough. From 2009 to 2014 he was CEO of Gilead Italy and on May 2014 he returned to Bristol Myers Squibb as President and Chief Executive Officer Italy. Tascione also served on the General Council of Confindustria and was member of Farmindustria Board and the Committee for the Ethical Code.

Zambon S.p.A. and Newron Pharmaceuticals S.p.A. Announce the Launch of Xadago

Zambon S.p.A., and its partner Newron Pharmaceuticals S.p.A. announced the launch of Xadago® (safinamide) in the Netherlands for the treatment of mid- to late-stage Parkinson’s disease (PD). Safinamide is now available in the Netherlands as an add-on therapy to a stable dose of levodopa (L-dopa) alone or in combination with other PD therapies for mid- to late-stage fluctuating patients providing a balanced control of motor symptoms and motor complications.

Similar Private Companies By Industry

Company Name Region
A. Menarini Industrie Farmaceutiche Riunite Srl Europe
Aboca S.p.A. - Societa Agricola Europe
ACME S.r.l. Europe
ACS Dobfar S.p.A. Europe
Agrisana S.R.L. Europe

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
The Advertising Council, Inc. United States
NYC2012, Inc. United States
Tax Management Inc United States
John F. Kennedy Center For The Performing Arts United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Zambon S.p.A., please visit Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at